Jefferies Group’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-8,300
| Closed | -$1.59M | – | 2919 |
|
|
2019
Q4 | $1.59M | Sell |
8,300
-83,100
| -91% | -$15M | 0.01% | 1177 |
|
|
2019
Q3 | $15.4M | Sell |
91,400
-204,100
| -69% | -$33.3M | 0.12% | 117 |
|
|
2019
Q2 | $49.5M | Buy |
295,500
+292,800
| +10,844% | +$40.5M | 0.36% | 28 |
|
|
2019
Q1 | $395K | Sell |
2,700
-93,700
| -97% | -$13.6M | ﹤0.01% | 1694 |
|
|
2018
Q4 | $12.9M | Buy |
96,400
+28,300
| +42% | +$4.64M | 0.11% | 149 |
|
|
2018
Q3 | $13M | Sell |
68,100
-71,400
| -51% | -$13.1M | 0.08% | 201 |
|
|
2018
Q2 | $23.3M | Buy |
139,500
+15,100
| +12% | +$2.42M | 0.13% | 99 |
|
|
2018
Q1 | $20.9M | Sell |
124,400
-150,600
| -55% | -$25.3M | 0.11% | 110 |
|
|
2017
Q4 | $45M | Buy |
275,000
+97,500
| +55% | +$17.5M | 0.21% | 55 |
|
|
2017
Q3 | $36.4M | Buy |
177,500
+5,600
| +3% | +$1.3M | 0.24% | 58 |
|
|
2017
Q2 | $41.8M | Sell |
171,900
-151,600
| -47% | -$35.6M | 0.28% | 50 |
|
|
2017
Q1 | $77.3M | Sell |
323,500
-1,019,900
| -76% | -$238M | 0.58% | 15 |
|
|
2016
Q4 | $282M | Sell |
1,343,400
-167,000
| -11% | -$34.6M | 1.58% | 5 |
|
|
2016
Q3 | $348M | Sell |
1,510,400
-288,500
| -16% | -$70.5M | 1.79% | 6 |
|
|
2016
Q2 | $416M | Buy |
1,798,900
+580,200
| +48% | +$134M | 1.89% | 8 |
|
|
2016
Q1 | $327M | Buy |
1,218,700
+46,700
| +4% | +$13.4M | 1.88% | 6 |
|
|
2015
Q4 | $366M | Buy |
1,172,000
+978,600
| +506% | +$291M | 2.08% | 6 |
|
|
2015
Q3 | $52.6M | Buy |
193,400
+148,800
| +334% | +$45.7M | 0.3% | 51 |
|
|
2015
Q2 | $13.5M | Sell |
44,600
-275,900
| -86% | -$82.3M | 0.07% | 228 |
|
|
2015
Q1 | $95.4M | Buy |
320,500
+5,100
| +2% | +$1.45M | 0.53% | 26 |
|
|
2014
Q4 | $81.2M | Sell |
315,400
-9,800
| -3% | -$2.45M | 0.48% | 36 |
|
|
2014
Q3 | $78.5M | Buy |
325,200
+92,400
| +40% | +$20.7M | 0.54% | 29 |
|
|
2014
Q2 | $51.9M | Buy |
+232,800
| New | +$48.2M | 0.44% | 43 |
|
|
2013
Q3 | – | Sell |
-130,000
| Closed | -$16.4M | – | 2294 |
|
|
2013
Q2 | $16.4M | Buy |
+130,000
| New | +$14.7M | 0.18% | 88 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Jefferies Group's AGN Position: Q2 2020 in Review
Jefferies Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 269,542 shares — an estimated $47.7M sold.
Jefferies Group first reported a position in AGN in Q2 2014 and held it in 24 quarters. The position peaked at $81.1M in Q2 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Jefferies Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Jefferies Group sold 269,542 Allergan plc shares in Q2 2020, an estimated $47.7M.
- Jefferies Group first reported a position in Allergan plc in Q2 2014 and held it in 24 quarters.
- Jefferies Group's Allergan plc position peaked at $81.1M in Q2 2016.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Jefferies Group's 13F filing for Q2 2020, filed 14 Aug 2020.